Overall, this strikes me as too hypothetical for us to apply, but what do I know?
"Overall, these findings illuminate a potential clinical path of using HDACi and optimized KD regimens to enhance ICB therapy for PCa."
HDACi = histone deacetylase inhibitor [To date, four HDAC inhibitors, Vorinostat, Romidepsin, Panobinostat, and Belinostat, have been approved by the United States Food and Drug Administration. Principally, these HDAC inhibitors are used for hematologic cancers in clinic with less severe side effects--NIH]
KD = ketogenic diet
ICB = immune checkpoint blockade